Consultant Clinical Oncologist
0161 446 3361
MA (Oxon.) BMBCh PGCME MD MRCP FRCR
Head and neck clinical oncology
Started at The Christie (Year)
Head and neck clinical oncology; treating patients with intensity-modulated radiotherapy, chemotherapy, biological and targeted therapies.
Patient referrals from Central Manchester and Leighton. Visiting Consultant Central Manchester Foundation Trust (2016-)
Dr Thomson qualified from Oxford University Medical School in 2004. He was awarded the Greenhill Exhibition in Medicine (Trinity College, Oxford) and achieved a First Class honours degree in Physiological Sciences (2001). He completed core medical training in Oxford and Manchester in 2009. He was then appointed Academic Clinical Fellow/Specialty Registrar in Clinical Oncology in the North West of England (2009-2015).
During a two year MD research degree at the University of Manchester (2013-2015), he gained excellent clinical and research experience in technical head and neck radiotherapy; and in proton beam therapy, with Fellowships in the United States (Massachusetts General Hospital, 2013; University of Pennsylvania, 2014). He also gained experience in stereotactic ablative radiotherapy for oligometastatic disease at Princess Alexandra Hospital, Brisbane (2015).
He is actively involved in clinical research, has a wide range of publications and presentations and is author of a book chapter on salivary gland radiotherapy. He is research lead for the Manchester Cancer Pathway Board. He is Deputy Chief Investigator for the UK phase III NIMRAD trial, responsible for radiotherapy quality assurance. He also has an interest in education and was awarded a Postgraduate Certificate in Medical Education with Distinction (Edge Hill University, 2015).
Dr Thomson was appointed Consultant Clinical Oncologist in 2015, with specialist interest in head and neck cancer. He is Honorary Senior Lecturer at the University of Manchester (2016-). At The Christie, he is involved in development of technical head and neck radiotherapy including MR Linac and proton beam therapy, and the clinical trials portfolio.
Advanced radiotherapy technologies and adaptation; proton beam therapy; salivary gland cancers; tumour hypoxia modification; clinical trials
Postgraduate medical education; radiotherapy quality assurance